Thirty-two Nebraska state senators joined Sen. Brad von Gillern’s letter calling on the Nebraska Board of Regents to delay a ...
An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback